# Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

> **NCT00002887** · PHASE1 · UNKNOWN · sponsor: **Ottawa Regional Cancer Centre** · enrollment: 30 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** etoposide
- **DRUG:** hydroxyurea
- **DRUG:** vinblastine sulfate
- **DRUG:** vindesine
- **DRUG:** vinorelbine tartrate
- **PROCEDURE:** drug resistance inhibition treatment

## Key facts

- **NCT ID:** NCT00002887
- **Lead sponsor:** Ottawa Regional Cancer Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1995-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002887, "Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00002887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*